Blood Flow Restriction Exercise Study

NCT02868021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-07-24

No results posted yet for this study

Summary

This pilot study will investigate the effects of blood flow restriction (BFR) exercise for up to 4-6 weeks prior to total knee arthroplasty (TKA) surgery in older patients to measure clinical outcomes such as strength, lower extremity function, and pain.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Strength testing

Test the strength of subject's lower extremity muscles on the dynamometer system

BEHAVIORAL

Short Physical Performance Battery (SPPB)

The SPPB is a timed short distance walk, repeated chair stands, and balance test that measures lower extremity function.

BEHAVIORAL

Six-minute walk (SMW)

Subjects walk back and forth along a 100-ft hallway for six minutes after instructions to complete as many laps as possible.

BEHAVIORAL

Numerical pain scale

Measure pain using an 11-point numerical pain scale.

BEHAVIORAL

Self-assessed function

Using the Late Life Function and Disability Instrument.

PROCEDURE

Muscle biopsies

During the course of the surgery two small muscle biopsies from the quadriceps muscle of the operative leg will be collected.

DEVICE

Determination of 1 Repetition Maximum (1-RM)

Following the warm-up, subjects will attempt to complete one repetition of the leg press exercise at progressively greater resistance until a full repetition can no longer be performed. The weight of the last complete unassisted repetition will be recorded as the 1-RM.

DEVICE

Blood flow restriction exercise

Perform lower-extremity exercises (leg press, leg extension, leg curl, and calf extension) at an intensity of 30% of 1-RM with external compression applied to the proximal thigh of each leg.

BEHAVIORAL

Borg CR10 scale

Following each exercise session, participants will provide a rating of perceived exertion (RPE) for the session according to the Borg CR10 scale.

Sponsors & Collaborators

  • University of Florida Clinical and Translational Science Institute (CTSI)

    collaborator UNKNOWN
  • University of Florida

    lead OTHER

Principal Investigators

  • Rene Przkora, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-12
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02868021 on ClinicalTrials.gov